Insulin at 100: a life-saving discovery but more remains to be done. 2021 marks the centenary of the discovery of insulin. It is important to remind ourselves that this life-saving medication still remains beyond the reach of many people with diabetes who need it. The International Diabetes Federation is leading a three-year World Diabetes Day […]
Safe and effective – wound healing preparation reaches clinical phase II: APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells. APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers (non-healing foot ulcers). The Data Safety Monitoring Board has therefore […]
Burns are extremely common, painful and potentially life-changing injuries. Burns frequently become infected and scarring from burns is often disfiguring and permanent. In fact, British hospitals treat 13,000 burns injuries each year. 200 people die from burns related injuries each year. Who is most at risk? A third of adult burns are work-related. Thus, those […]
IDF : Diabetes is “a pandemic of unprecedented magnitude” now affecting one in 10 adults worldwide: London, UK, November 2, The International Diabetes Federation (IDF) has released new figures showing that 537 million adults are now living with diabetes worldwide — a rise of 16% (74 million) since the previous IDF estimates in 2019. Released […]
Read More… from IDF: Diabetes is a pandemic of unprecedented magnitude
Increased consumption of whole grain foods could significantly reduce the incidence of type 2 diabetes and the costs associated with its treatment in Finland, according to a recent study by the University of Eastern Finland and the Finnish Institute for Health and Welfare. The findings were published in Nutrients. “Our study shows that already one […]
Read More… from Whole grain food and the economics of type 2 diabetes
A calculator to help people understand their risk factors for COVID-19 infection and vaccination has been launched by the Immunisation Coalition in collaboration with Australian researchers. The tool’s three co-lead researchers are University of Queensland virologist Dr Kirsty Short, CoRiCal instigator from Flinders University Associate Professor John Litt and GP Dr Andrew Baird. Dr Kirsty Short said the Immunisation Coalition COVID-19 […]
Read More… from COVID-19 risks explained with new calculator
WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists: High prices and low availability still a major barrier for patients’ access to new and old medicines. WHO has published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, […]
News Release: Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared […]
Read More… from Merck and Ridgeback’s Antiviral Molnupiravir trial
Diabetes UK responds to discussion on huge and growing primary care needs of people with diabetes who have survived COVID-19 at EASD. Nikki Joule, Policy Manager at Diabetes UK, said: “People with diabetes have been disproportionately affected by the pandemic, with a third of Covid-19 deaths in England occurring in those with diabetes during the […]
Diabetes UK responds to study investigating impact of lockdown on diabetes control The meta-analysis, presented at the Annual Meeting of the European Association for the Study of Diabetes, suggested that blood sugar control improved in people with type 1 diabetes, whereas lockdown contributed to a short-term worsening in blood sugar control in many people with […]
Read More… from Diabetes UK responds to diabetes lockdown study